Reply letter to “COVID-19 and Recurrent Status Epilepticus"

Main Article Content

Giada Pauletto
Annacarmen Nilo
Cristian Deana
Lorenzo Verriello
Ilaria Del Negro
Christian Lettieri
Luigi Vetrugno
Mariarosaria Valente
Gian Luigi Gigli

Keywords

status epilepticus, SARS-CoV-2 infection, neuroinflammation

Downloads

Download data is not yet available.
Abstract 73 | PDF Downloads 44

References

1. Pauletto G., Nilo A., Deana C., Verriello L., Del Negro I., Lettieri C., Vetrugno L., Valente M., Gigli G.L. Recurrent Status Epilepticus and SARS-CoV-2 infection: the perfect storm. Acta Biomedica 2021; Vol 92, N.5: e2021208

2. C. Deana, L. Verriello, G. Pauletto, F. Corradi, F. Forfori, G. Cammarota, E. Bigani, L. Vetrugno, T. Bove. Insight into neurological dysfunction in critically ill COVID-19 patients. Trends in Anaesthesia and Critical Care, 2020.

3. A. Vezzani, R. Dingledine and A. O. Rossetti. Immunity and inflammation in Status Epilepticus and its sequelae: possibility for therapeutic application. Expert Rev Neurother 2015; 15(9): 1081- 1092. doi: 10.1586/14737175.2015.1079130

4. M. Belluzzo, A. Nilo, M. Valente, G. L. Gigli. New-onset status epilepticus in SARS-CoV-2 infection: a case series. Neurol Sci. 2021 Aug 16: 1-6. doi: 10.1007/s10072-021-05536-0

Most read articles by the same author(s)

<< < 1 2